Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration

Toxicon

Volumn 53, Issue 4, 2009, Pages 444-453

  Zouari Kessentini, Raoudha ^a   Luis, José ^b   Karray, Aida ^c   Kallech Ziri, Olfa ^a   Srairi Abid, Najet ^a   Bazaa, Amine ^a   Loret, Erwann ^b   Bezzine, Sofiane ^c   El Ayeb, Mohamed ^a   Marrakchi, Naziha ^a,d  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b University of the Mediterranean Aix Marseille II   (France)

^c UNIVERSITY OF SFAX   (Tunisia)

^d UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Cell adhesion; Cell migration; Secreted phospholipase A2; Venom

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CARBON; FIBRINOGEN; FIBRONECTIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP I; PHOSPHOLIPASE A2 GROUP II; SEPHADEX; SNAKE VENOM;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CANCER CELL; CELL ADHESION; CELL LINE; CELL MIGRATION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME PURIFICATION; FIBROSARCOMA; GEL FILTRATION; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MELANOMA; MOLECULAR WEIGHT; NONHUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

CERASTES CERASTES;

EID: 60449094739     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.01.003     Document Type: Article

References (44)

1. Altschul S.F., Thomas L.M., Alejandro A.S., Jinghui Z., Webb M., and David J.L. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997)
2. Andriao-Escarso S.H., Soares A.M., Rodrigues V.M., Angulo Y., Diaz C., Lomonte B., Gutierrez J.M., and Giglio J.R. Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothrops toxins from Bothrops jararacussu. Biochim. 82 (2000) 755-763
3. Arni R.K., and Ward R.J. Phospholipase A2 - a structural review. Toxicon 34 (1996) 827-841
4. Bazaa A., Marrakchi N., El Ayeb M., Sanz L., and Calvete J.J. Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Proteomics 5 (2005) 4223-4235
5. Born G.V.R., and Cross M.J. The aggregation of blood platelets. J. Physiol. 168 (1963) 178-195
6. Chippaux J.P., Williams V., and White J. Snake venom variability: methods of study, results and interpretation. Toxicon 29 (1991) 1279-1303
7. Conde R., Zamudio F.Z., Becerril B., and Possani L.D. Phospholipin, a novel heterodimeric phospholipase A2 from Pandinus imperator scp6pion venom. FEBS Lett. 460 (1999) 447-450
8. Davidson F.F., and Dennis E.A. Evolutionary relationships and implications for the regulation of phospholipase A2 from snake venom to human secreted forms. J. Mol. Evol. 31 (1990) 228-238
9. Djebari F.L., and Martin-Eauclaire M.F. Purification and characterization of a phospholipase A2 from Cerastes cerastes (horn viper) snake venom. Toxicon 28 (1990) 637-646
10. Dong M., Guda K., Nambiar P.R., Rezaie A., Belinsky G.S., Lambeau G., Giardina C., and Rosenberg D.W. Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis 24 (2003) 307-315
11. Evans J., and Ownby C.L. Neutralization of edema, hemorrhage and myonecrosis induced by North American crotalid venoms in simulated first-aid treatments. Toxicon 37 (1999) 633-650
12. Francischetti I.M., Gombarovits M.E., Valenzuela J.G., Carlini C.R., and Guimaraes J.A. Intraspecific variation in the venoms of the South American rattlesnake (Crotalus durissus terrificus). Comp. Biochem. Physiol. C, Toxicol. Pharmacol. 127 (2000) 23-36
13. Fuly A.L., Calil-Elias S., Martinez A.M., Melo P.A., and Guimaraes J.A. Myotoxicity induced by an acidic Asp-49 phospholipase A(2) isolated from Lachesis muta snake venom. Comparison with lysophosphatidylcholine. Int. J. Biochem. Cell Biol. 35 (2003) 1470-1481
14. Gukovskaya A.S., Arias Pulido H., Petrunyaka V.V., Zinchenko V.P., and Bezuglov V.V. Lipoxygenase inhibitors suppress intracellular calcium rise induced by ionomycin in rat thymocytes. Cell Calcium 11 (1990) 539-546
15. Harris L.K., and Franson R.C. [1-14C]oleate-labeled autoclaved yeast: a membranous substrate for measuring phospholipase A2 activity in vitro. Anal. Biochem. 193 (1991) 191-196
16. Hawgood B.J. Professor Chen-Yuan Lee, MD (1915-2001), pharmacologist: snake venom research at the Institute of Pharmacology, National Taiwan University. Toxicon 40 (2002) 1065-1072
17. Higuchi M., Shirotani K., Higashi N., Toyoshima S., and Osawa T. Damage to mitochondrial respiration chain is related to phospholipase A2 activation caused by tumor necrosis factor. J. Immunother. 12 (1992) 41-49
18. Hoffman D.R. Allergens in hymenoptera venom. XXVI: the complete amino acid sequences of two vespid venom phospholipases. Int. Arch. Allergy Immunol. 104 (1994) 184-190
19. Huang M.Z., Gopalakrishnakone P., and Kini R.M. Role of enzymatic activity in the antiplatelet effects of a phospholipase A2 from Ophiophagus hannah snake venom. Life Sci. 61 (1997) 2211-2217
20. Jensen L.B., Burgess N.K., Gonda D.D., Spencer E., Wilson-Ashworth H.A., Driscoll E., Vu M.P., Fairbourn J.L., Judd A.M., and Bell J.D. Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2. Biophys. J. 88 (2005) 2692-2705
21. Joubert F.J., Townshend G.S., and Botes D.P. Snake venoms. Purification, some properties of two phospholipases A2 (CM-I and CM-II) and the amino-acid sequence of CM-II and Bitis nasicornis (horned adder) venom. Hoppe Seyler's Z. Physiol. Chem. 364 (1983) 1717-1726
22. Kini R.M. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 42 (2003) 827-840
23. Kini R.M., and Evans H.J. Correlation between the enzymatic activity, anticoagulant and antiplatelet effects of phospholipase A2 isoenzymes from Naja nigricollis venom. Thromb. Haemost. 60 (1988) 170-173
24. Kini R.M., and Evans H.J. A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 27 (1989) 613-635
25. Kini R.M., and Evans H.J. Effects of snake venom proteins on blood platelets. Toxicon 28 (1990) 1387-1422
26. Lotan A., Fishman L., and Zlotkin E. Toxin compartmentation and delivery in the Cnidaria: the nematocyst's tubule as a multiheaded poisonous arrow. J. Exp. Zool. 275 (1996) 444-451
27. Maity G., Mandal S., Chatterjee A., and Bhattacharyya D. Purification and characterization of a low molecular weight multifunctional cytotoxic phospholipase A2 from Russell's viper venom. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 845 (2007) 232-243
28. McIntosh J.M., Ghomashchi F., Gelb M.H., Dooley D.J., Stoehr S.J., Giordani A.B., Naisbitt S.R., and Olivera B.M. Conodipine-M, a novel phospholipase A2 isolated from the venom of the marine snail Conus magus. J. Biol. Chem. 270 (1995) 3518-3526
29. Moreno J.J. Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation. Immunopharmacology 26 (1993) 1-9
30. Norma A.V.-C., Batista C.V.F., and Lourival D.P. Phaiodactylipin, a glycosylated heterodimeric phospholipase A2 from the venom of the scorpion Anuroctonus phaiodactylus. FEBS J. 271 (2004) 1453-1464 (1412)
31. Olfa K.Z., Jose L., Salma D., Amine B., Najet S.A., Nicolas A., Maxime L., Raoudha Z., Kamel M., Jacques M., Jean-Marc S., Mohamed el A., and Naziha M. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis. Lab Invest. 85 (2005) 1507-1516
32. Oscar H.P.R., Alexandre K., Márcia R.C., Iga B., Carmen L.S.P., Fabrice C., Jan M., Roger V., Marco G., Chantal L., Heloisa S.S.-d.-A., Michel C., and Arnaud B. A novel avb3-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis. Clin. Exp. Metastasis 25 (2008) 53-64
33. Ouyang Y., and Kaminski N.E. Phospholipase A2 inhibitors p-bromophenacyl bromide and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes. Arch. Toxicol. 73 (1999) 1-6
34. Pilorget A., Conesa M., Sarray S., Michaud-Levesque J., Daoud S., Kim K.S., Demeule M., Marvaldi J., El Ayeb M., Marrakchi N., Beliveau R., and Luis J. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo. J. Cell Physiol. 211 (2007) 307-315
35. Siddiqui A.R., Shafkat J., Zaidi J.H., and Jörnval H. Characterization of phospholipase A2 from the venom of Horned viper (Cerastes cerastes). FEBS Lett. 278 1 (1991) 14-16
36. Rigot V., Lehmann M., Andre F., Daemi N., Marvaldi J., and Luis J. Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J. Cell Sci. 111 Pt 20 (1998) 3119-3127
37. Roberto P.G., Kashima S., Marcussi S., Pereira J.O., Astolfi-Filho S., Nomizo A., Giglio J.R., Fontes M.R., Soares A.M., and Franca S.C. Cloning and identification of a complete cDNA coding for a bactericidal and antitumoral acidic phospholipase A2 from Bothrops jararacussu venom. Protein J. 23 (2004) 273-285
38. Roelofsen B., Trip M.S., Verheij H.M., and Zevenbergen J.L. The action of cobra venom phospholipase A2 isoenzymes towards intact human erythrocytes. Biochim. Biophys. Acta 600 (1980) 1012-1017
39. Rouault M., Rash L.D., Escoubas P., Boilard E., Bollinger J., Lomonte B., Maurin T., Guillaume C., Canaan S., Deregnaucourt C., Schrevel J., Doglio A., Gutierrez J.M., Lazdunski M., Gelb M.H., and Lambeau G. Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity. Biochemistry 45 (2006) 5800-5816
40. Spiro R.G. Analysis of sugars found in glycoproteins. Meth. Enzymol. 256 (1966) 3-26
41. Teng C.M., Kuo Y.P., Lee L.G., and Ouyang C. Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophophatidylcholine. Thromb. Res. 44 (1986) 875-886
42. Valentin E., and Lambeau G. Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim. Biophys. Acta 1488 (2000) 59-70
43. 2+ channels. Brain Res. 960 (2003) 71-80
44. Yuan Y., Jackson S.P., Newnham H.H., Mitchell C.A., and Salem H.H. An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2. Blood 86 (1995) 4166-4174